SERVICE

Protein analysis services, microbial-based innovation consulting, and manufacturing and supply of analytical equipment and consumables.

  • 1. Leverage microbes to produce high concentrations of useful substances and optimize processes

    It focuses on using microorganisms to produce high-value materials, solve problems in production, and increase production efficiency.

    • Production of high-value-added materials: high yield/high concentration production of amino acids, nucleic acids, etc.
    • Troubleshooting production site issues: Identify and resolve causes of production site amino acid/nucleic acid denaturation
    • Process optimization: optimization of fermentation media/process conditions based on factorial design of experiments, fermenter operation (batch, fed-batch, continuous culture)

    Reference Image
    https://www.google.com/url?sa=i&url=https%3A%2F%2Flink.springer.com%2Fchapter%
    2F10.1007%2F978-3-030-39267-3_7&psig=AOvVaw3FvLomDvS99E6A1P3GLoTG&ust=
    1729247930614000&source=images&cd=vfe&opi=89978449&ved=0CBQQjRxqFwoTCICcp
    NeclYkDFQAAAAAdAAAAABAw

  • 2. Multiomics-based sample analysis and development of useful substance-producing strains

    2. It focuses on analyzing various omics data, including the genome, transcriptome, proteome, and metabolome of microorganisms, to understand their function and develop strains with desired characteristics.

    • Multomics data analysis: Generate and integrate multiomics (genomic, transcriptomic, proteomic, metabolomic, etc.) data, set up and analyze multiomics.
    • Strain development: multiomics-based strain and process development target selection and validation, metabolic engineering-based strain development, and adaptive mutagenesis to confer resistance to the product



      • Reference Image
      https://doi.org/10.3389/fbioe.2021.613307

  • 3. Develop microbiome-based Live Biotherapeutic Products

    It focuses on using the microbiome to develop new therapeutics and develop technologies for personalized medicine.

    • Microbiome-based drug discovery: Development of microbiome-based drugs and next-generation probiotics, multiomics-based cohort studies for selection of human-derived beneficial microbes, isolation/identification/genomic analysis of cohort fecal-derived anaerobic microbes, efficacy evaluation and preclinical mechanism of action studies of Live Biotherapeutic Products (LBPs), production and purification of LBPs.
    • Discovering new projects : Discovering and planning new projects such as prebiotics/synbiotics/pharmabiotics


      • Reference Image
      https://doi.org/10.1007/s40588-023-00213-6

  • 4. Other

    We offer consulting in a variety of areas, including microbiology, analysis of substances in samples, personalized nutrition, and more.

    • Materials analysis: basic analysis and various mass spectrometry for sample characterization, separation/purification/identification of unknown compounds
    • Personalized Nutrition: Personalized Precision Nutrition Powered by Nutriomics


      • Reference Image
      https://emerypharma.com/wp-content/uploads/2022/11/LCMS-website-content-
      picture-1-1.png


      Reference Image
      https://doi.org/10.24875/ric.21000346